News
Some proponents worry they could lose credibility if they are rushed onto the market or are too closely tied to Kennedy.
Nearly six months into President Trump’s second term, The Hill and NewsNation team up to host the inaugural Hill Nation ...
30mon MSN
The FDA revealed the recall for the deodorant on its website, saying it affected more than 67,000 cases of the product. The ...
The U.S. Food and Drug Administration has issued seven warning letters to companies illegally marketing products containing 7-hydroxymitragynine (7-OH), which is found in trace amounts in kratom.
A coalition of 45 marijuana advocacy and medical groups—including Americans for Safe Access (ASA), U.S. Pain Foundation, ...
The two spent time in a hyperbaric oxygen chamber and tried some intravenous nutrition drips that Brecka, a self-avowed longevity and wellness maven, sells and promotes on his show, “The Ultimate ...
Explore more
A separate analysis of the real-world trial found that those who switched from daily antiretroviral treatment to Cabenuva had fewer concerns about treatment.
Recent health headlines include FDA's eye safety concerns over GSK's cancer drug, escalating malnutrition rates in Gaza ...
The warning reflects growing concern over a surge in opioid products marketed to US consumers containing concentrated levels of 7-hydroxymitragynine (7-OH).
The FDA has lifted one of the two clinical holds placed on Kezar Life Sciences’ zetomipzomib, leading the biotech to speculate on whether to reignite another program for the same drug that remains ...
Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...
The U.S. Food and Drug Administration's staff reviewers on Wednesday raised efficacy concerns over Otsuka Pharma's combination treatment for adults with post-traumatic stress disorder (PTSD), citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results